Michael W. Flanagan
Insider
First SEC filing: Feb. 27, 2026 · Latest: Feb. 27, 2026
Insider transactions
0 buys (P)
3 sells (S)
Net: $-644,790
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | RNA | D | 50,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 88,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 72,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 96,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 66,500 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 25,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 150,365 | · | · | 0 Direct | -100.00% | Disposed | |
| Jan. 21, 2026 | RNA | S 10b5-1 | 3,976 | $72.45 | $288,061 | 87,651 Direct | -4.34% | Disposed | |
| Jan. 21, 2026 | RNA | S 10b5-1 | 2,558 | $72.45 | $185,327 | 85,093 Direct | -2.92% | Disposed | |
| Jan. 7, 2026 | RNA | S 10b5-1 | 2,373 | $72.23 | $171,402 | 91,627 Direct | -2.52% | Disposed | |
| Dec. 17, 2025 | RNA | A | 27,500 | · | · | 107,695 Direct | +34.29% | Acquired | |
| Dec. 17, 2025 | RNA | F | 13,695 | $71.87 | $984,260 | 94,000 Direct | -12.72% | Disposed | |
| Sept. 11, 2025 | RNA | M 10b5-1 | 20,000 | $14.22 | $284,400 | 100,195 Direct | +24.94% | Acquired | |
| Sept. 11, 2025 | RNA | S 10b5-1 | 20,000 | $38.94 | $778,800 | 80,195 Direct | -19.96% | Disposed | |
| Sept. 11, 2025 | RNA | M 10b5-1 | 20,000 | · | · | 76,500 Direct | -20.73% | Disposed | |
| June 11, 2025 | RNA | M 10b5-1 | 20,000 | $14.22 | $284,400 | 100,195 Direct | +24.94% | Acquired | |
| June 11, 2025 | RNA | S 10b5-1 | 20,000 | $32.88 | $657,600 | 80,195 Direct | -19.96% | Disposed | |
| June 11, 2025 | RNA | M 10b5-1 | 20,000 | · | · | 96,500 Direct | -17.17% | Disposed | |
| March 20, 2025 | RNA | S 10b5-1 | 11,780 | $31.06 | $365,887 | 80,195 Direct | -12.81% | Disposed | |
| March 11, 2025 | RNA | M 10b5-1 | 20,000 | $14.22 | $284,400 | 111,975 Direct | +21.75% | Acquired | |
| March 11, 2025 | RNA | S 10b5-1 | 20,000 | $30.13 | $602,600 | 91,975 Direct | -17.86% | Disposed | |
| March 11, 2025 | RNA | M 10b5-1 | 20,000 | · | · | 116,500 Direct | -14.65% | Disposed | |
| Jan. 21, 2025 | RNA | S 10b5-1 | 3,860 | $28.60 | $110,396 | 93,787 Direct | -3.95% | Disposed | |
| Jan. 21, 2025 | RNA | S 10b5-1 | 1,812 | $28.59 | $51,805 | 91,975 Direct | -1.93% | Disposed | |
| Jan. 6, 2025 | RNA | A | 25,000 | · | · | 97,647 Direct | +34.41% | Acquired | |
| Jan. 6, 2025 | RNA | A | 50,000 | · | · | 50,000 Direct | · | Acquired | |
| Dec. 18, 2024 | RNA | S 10b5-1 | 12,742 | $32.66 | $416,154 | 72,647 Direct | -14.92% | Disposed | |
| Dec. 11, 2024 | RNA | M 10b5-1 | 24,000 | $22.47 | $539,280 | 109,389 Direct | +28.11% | Acquired | |
| Dec. 11, 2024 | RNA | S 10b5-1 | 24,000 | $35.77 | $858,480 | 85,389 Direct | -21.94% | Disposed | |
| Dec. 11, 2024 | RNA | M 10b5-1 | 24,000 | · | · | 86,000 Direct | -21.82% | Disposed | |
| Oct. 1, 2024 | RNA | M 10b5-1 | 62,500 | $26.75 | $1,671,875 | 147,889 Direct | +73.19% | Acquired | |
| Oct. 1, 2024 | RNA | S 10b5-1 | 62,500 | $47.62 | $2,976,250 | 85,389 Direct | -42.26% | Disposed | |
| Oct. 1, 2024 | RNA | M 10b5-1 | 62,500 | · | · | 25,000 Direct | -71.43% | Disposed | |
| Sept. 23, 2024 | RNA | S 10b5-1 | 13,153 | $44.00 | $578,732 | 72,718 Direct | -15.32% | Disposed | |
| Sept. 23, 2024 | RNA | S 10b5-1 | 11,847 | $43.89 | $519,965 | 85,389 Direct | -12.18% | Disposed | |
| Sept. 19, 2024 | RNA | A | 25,000 | · | · | 85,871 Direct | +41.07% | Acquired | |
| Sept. 19, 2024 | RNA | A | 25,000 | · | · | 97,718 Direct | +34.38% | Acquired | |
| Sept. 11, 2024 | RNA | M 10b5-1 | 62,500 | $26.75 | $1,671,875 | 138,265 Direct | +82.49% | Acquired | |
| Sept. 11, 2024 | RNA | S 10b5-1 | 62,500 | $40.40 | $2,525,000 | 75,765 Direct | -45.20% | Disposed | |
| Sept. 11, 2024 | RNA | M 10b5-1 | 34,000 | $22.47 | $763,980 | 109,765 Direct | +44.88% | Acquired | |
| Sept. 11, 2024 | RNA | S 10b5-1 | 34,000 | $40.40 | $1,373,600 | 75,765 Direct | -30.98% | Disposed | |
| Sept. 11, 2024 | RNA | S 10b5-1 | 14,894 | $40.40 | $601,718 | 60,871 Direct | -19.66% | Disposed | |
| Sept. 11, 2024 | RNA | M 10b5-1 | 62,500 | · | · | 87,500 Direct | -41.67% | Disposed | |
| Sept. 11, 2024 | RNA | M 10b5-1 | 34,000 | · | · | 110,000 Direct | -23.61% | Disposed | |
| June 18, 2024 | RNA | S 10b5-1 | 10,106 | $39.13 | $395,448 | 50,765 Direct | -16.60% | Disposed | |
| June 17, 2024 | RNA | A | 25,000 | · | · | 60,871 Direct | +69.69% | Acquired | |
| June 17, 2024 | RNA | A | 25,000 | · | · | 75,765 Direct | +49.25% | Acquired | |
| Jan. 22, 2024 | RNA | S 10b5-1 | 4,129 | $10.13 | $41,827 | 35,871 Direct | -10.32% | Disposed | |
| Jan. 20, 2024 | RNA | A | 20,000 | · | · | 20,290 Direct | +6896.55% | Acquired | |
| Jan. 20, 2024 | RNA | A | 88,000 | · | · | 88,000 Direct | · | Acquired | |
| Sept. 11, 2023 | RNA | A | 72,000 | · | · | 72,000 Direct | · | Acquired | |
| Jan. 20, 2023 | RNA | A | 144,000 | · | · | 144,000 Direct | · | Acquired | |
| Jan. 20, 2023 | RNA | A | 40,000 | · | · | 40,290 Direct | +13793.10% | Acquired | |
| Jan. 21, 2022 | RNA | A | 136,500 | · | · | 136,500 Direct | · | Acquired | |
| Jan. 21, 2021 | RNA | A | 150,000 | · | · | 150,000 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $31.42 | Jan. 5, 2035 | 50,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $10.16 | Jan. 19, 2034 | 88,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $6.57 | Sept. 10, 2033 | 72,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 96,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 66,500 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $26.75 | Jan. 20, 2031 | 25,000 | Disposed |
| Sept. 11, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 20,000 | Disposed |
| June 11, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 20,000 | Disposed |
| March 11, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 20,000 | Disposed |
| Jan. 6, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $31.42 | Jan. 5, 2035 | 50,000 | Acquired |
| Dec. 11, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 24,000 | Disposed |
| Oct. 1, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $26.75 | Jan. 20, 2031 | 62,500 | Disposed |
| Sept. 11, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $26.75 | Jan. 20, 2031 | 62,500 | Disposed |
| Sept. 11, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 34,000 | Disposed |
| Jan. 20, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $10.16 | Jan. 19, 2034 | 88,000 | Acquired |
| Sept. 11, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $6.57 | Sept. 10, 2033 | 72,000 | Acquired |
| Jan. 20, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $22.47 | Jan. 19, 2033 | 144,000 | Acquired |
| Jan. 21, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $14.22 | Jan. 20, 2032 | 136,500 | Acquired |
| Jan. 21, 2021 | RNA | Stock Option (Right to Buy) | Common Stock | $26.75 | Jan. 20, 2031 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CIK 1599901
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $500,300 | · | $3,315,040 | $632,746 | $337,800 | · | $17,010 | $4,802,896 |
| 2023 | $470,600 | · | $4,210,742 | · | $188,240 | · | $16,379 | $4,885,962 |
| 2022 | $422,000 | · | · | · | $241,400 | · | $15,336 | $2,065,986 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.